The abuse of alcohol, one of the well-liked psychoactive substances, may cause a number of pathological and psychological penalties, together with alcohol use dysfunction (AUD). An impaired capability to cease or management alcohol consumption regardless of opposed well being or social penalties characterize AUD. Whereas AUDs predominantly happen in males, rising proof suggests the existence of distinct cognitive and organic penalties of alcohol dependence in ladies. The molecular and physiological mechanisms taking part in these differential results stay unknown. Transcriptomic know-how permits the detection of the organic mechanisms accountable for such sex-based variations, which helps the following improvement of novel personalised therapeutics to deal with AUD.
We performed a scientific evaluate and meta-analysis of transcriptomics research concerning alcohol dependence in people with illustration from each sexes. For every examine, we processed and analyzed transcriptomic information to acquire a purposeful profile of pathways and organic capabilities after which built-in the ensuing information by meta-analysis to characterize any sex-based transcriptomic variations related to AUD.
International outcomes of the transcriptomic evaluation revealed the affiliation of decreased tissue regeneration, embryo malformations, altered intracellular transport, and elevated charge of RNA and protein substitute with feminine AUD sufferers. In the meantime, our evaluation indicated that elevated inflammatory response and blood stress and a discount in DNA restore capabilities are related to male AUD sufferers. In abstract, our purposeful meta-analysis of transcriptomic research gives proof for differential organic mechanisms of AUD sufferers of differing intercourse.
The sector of artificial biology heralds a brand new period in our relationship with nature, as organisms are engineered to satisfy human targets. However little consideration has been paid to potential cognitive constraints on reasoning about such applied sciences. Throughout 4 research with American adults (N = 649), the current analysis investigates the proposal that essentialist reasoning and ethical purity issues conspire to form danger assessments of engineered organisms. Ethical purity issues however not ethical hurt issues predict ethical wrongness judgments of including a overseas gene to a plant (Research 1, 2 & 4), in addition to assessments of danger (Research 1 and a couple of), and danger of hurt from consuming (Examine 4).
Including a gene from a taxonomically distant organism is taken into account extra morally flawed (Research 2, Three and 4), extra dangerous (Research 2 & 3), and extra dangerous to eat (Examine 4), than including both a gene from an identical organism or a new-to-nature gene. Assessments of the chance of gene unfold comply with a special sample, with the new-to-nature gene thought-about most secure (Examine 4). The findings help the proposal that gene change is reasoned about as essence change that threatens notions of ethical purity, with direct implications for sure kinds of danger perceptions (consuming), however not others (gene unfold).
Modeling a Cognitive Transition on the Origin of Cultural Evolution Utilizing Autocatalytic Networks
Autocatalytic networks have been used to mannequin the emergence of self-organizing construction able to sustaining life and present process organic evolution. Right here, we mannequin the emergence of cognitive construction able to present process cultural evolution. Psychological representations (MRs) of information and experiences play the function of catalytic molecules, and interactions amongst them (e.g., the forging of latest associations) play the function of reactions and end in representational redescription. The method tags MRs with their supply, that’s, whether or not they had been acquired by way of social studying, particular person studying (of pre-existing info), or inventive thought (ensuing within the era of latest info). This makes it doable to mannequin how cognitive construction emerges and to hint lineages of cumulative tradition step-by-step.
We develop a proper illustration of the cultural transition from Oldowan to Acheulean instrument know-how utilizing Reflexively Autocatalytic and Meals set generated (RAF) networks. In contrast to extra primitive Oldowan stone instruments, the Acheulean hand axe required not solely the capability to examine and convey into being one thing that didn’t but exist, however hierarchically structured thought and motion, and the era of latest MRs: the ideas EDGING, THINNING, SHAPING, and a meta-concept, HAND AXE. We present how this constituted a key transition towards the emergence of semantic networks that had been self-organizing, self-sustaining, and autocatalytic, and we focus on how such networks replicated by way of social interplay. The mannequin gives a promising method to unraveling one of many biggest anthropological mysteries: that of why improvement of the Acheulean hand axe was adopted by over one million years of cultural stasis.
Starting of life ethics on the daybreak of a brand new period of genome modifying: are bioethical precepts and fast-evolving biotechnologies irreconcilable?
The superb and virtually unimaginable advances which have unfolded over the previous a long time in biotechnologies (heritable germline modifying particularly) have introduced bioethical points to the forefront, sparking public debate and growing consideration worldwide. Such mind-blowing progress has already resulted in main enchancment and enhancements for people, and holds the potential for much more. Expertise and bioengineering have begun to take over within the life sciences trade.
Man’s capability to genetically engineer the organic world is nothing in need of mind-boggling in its present magnitude, and will even evolve, in a not too distant future, into makes an attempt to fuse man and machine right into a cohesive bioengineered entity; a “tremendous human being”, endowed with enhanced cognitive and bodily capabilities and impervious to illness, could also be not too far down the highway. That won’t come with out caveats, nevertheless.
Purified (CHO cells) Recombinant Human BMP7 protein, Biologically active |
BMP75-R-10 |
Alpha Diagnostics |
10 ug |
EUR 1074 |
Purified Human Angiostatin (Kringles 1-4) protein (>98%), biologically active |
ANST11-R |
Alpha Diagnostics |
100 ug |
EUR 416.4 |
Recombinant purified human GST-mu (GST-M1) protein biologically active |
GSTM25-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-mu (GST-M1) protein biologically active |
GSTM25-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified human GST-pi (GST-P1) protein biologically active |
GSTP35-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-pi (GST-P1) protein biologically active |
GSTP35-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified human GST-alpha (GST-A1) protein biologically active |
GSTA15-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-alpha (GST-A1) protein biologically active |
GSTA15-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-100 |
Alpha Diagnostics |
100 ug |
EUR 562.8 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 1951.2 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-250 |
Alpha Diagnostics |
250 ug |
EUR 854.4 |
Recombinant purified human GST-T1-1 (GST T1-1) protein biologically active |
GSTT45-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-T1-1 (GST T1-1) protein biologically active |
GSTT45-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified Human Heme Oxygenase 2 (HO-2) protein (biologically active) |
HO25-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified human GST-alpha 3 (GST A3-3) protein biologically active |
GSTA35-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-alpha 3 (GST A3-3) protein biologically active |
GSTA35-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Purified (E.Coli) Recombinant Human BMP2 protein, Biologically active, Carrier free |
BMP25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 1074 |
Mouse Recombinant Purified Noggin-Fc protein, biologically active |
NOGN25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Mouse Recombinant Purified Noggin-Fc protein, biologically active |
NOGN25-R-25 |
Alpha Diagnostics |
25 ug |
EUR 781.2 |
Mouse Recombinant Purified Noggin protein (E. coli), biologically active |
NOGN26-R-20 |
Alpha Diagnostics |
20 ug |
EUR 781.2 |
Mouse Recombinant Purified Noggin protein (E. coli), biologically active |
NOGN26-R-5 |
Alpha Diagnostics |
5 ug |
EUR 343.2 |
Human Recombinant (E.Coli) Angiostatin Kringles 1-3 purified protein biologically active |
ANKR131-R-250 |
Alpha Diagnostics |
250 ug |
EUR 927.6 |
Human Recombinant (E.Coli) Angiostatin Kringles 1-3 purified protein biologically active |
ANKR131-R-50 |
Alpha Diagnostics |
50 ug |
EUR 270 |
Recombinant purified Rat Heme Oxygenase 1 (HO-1) protein (biologically active) |
HO15-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified Mouse Endostatin protein (P. Pastoris) biologically active, low endotoxin |
ENST15-R-100 |
Alpha Diagnostics |
100 ug |
EUR 562.8 |
Recombinant purified Mouse Endostatin protein (P. Pastoris) biologically active, low endotoxin |
ENST15-R-250 |
Alpha Diagnostics |
250 ug |
EUR 854.4 |
Purified Recombinant Human BMP-13 (CDMP-2/GDF-6), Biologically active, Carrier free |
BMP135-R-10 |
Alpha Diagnostics |
10 ug |
EUR 489.6 |
Purified Recombinant Human BMP-13 (CDMP-2/GDF-6), Biologically active, Carrier free |
BMP135-R-50 |
Alpha Diagnostics |
50 ug |
EUR 1074 |
Purified Recombinant Human BMP-14 (CDMP-1/GDF-5), Biologically active, Carrier free |
BMP145-R-10 |
Alpha Diagnostics |
10 ug |
EUR 489.6 |
Purified Recombinant Human BMP-14 (CDMP-1/GDF-5), Biologically active, Carrier free |
BMP145-R-50 |
Alpha Diagnostics |
50 ug |
EUR 1074 |
Recombinant (E. coli), purified, Human beta-Defensin 4 (BD-4/hBD-4) full length protein (50 aa), biologically active |
HBD45-R-20 |
Alpha Diagnostics |
20 ug |
EUR 708 |
Recombinant (E. coli), purified, Human beta-Defensin 4 (BD-4/hBD-4) full length protein (50 aa), biologically active |
HBD45-R-5 |
Alpha Diagnostics |
5 ug |
EUR 343.2 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 270 |
Recombinant (E. coli), purified, Mouse beta-Defensin 2 (BD-2/mBD-2) full length protein, biologically active |
MBD25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 548.4 |
Recombinant (E.Coli), purified, Human beta-Defensin 3 (BD-3/hBD-3, full length peptide (45 aa), biologically active |
HBD37-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (E.Coli), purified, Human beta-Defensin 3 (BD-3/hBD-3, full length peptide (45 aa), biologically active |
HBD37-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2617.2 |
Recombinant (E.Coli), purified, Human beta-Defensin 3 (BD-3/hBD-3, full length peptide (45 aa), biologically active |
HBD37-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 7221.6 |
Recombinant (E. coli), purified, Human beta-Defensin 1 (BD-1/hBD-1) full length peptide (36 aa), biologically active |
HBD17-R-10 |
Alpha Diagnostics |
10 ug |
EUR 460.8 |
Recombinant (E. coli), purified, Human beta-Defensin 1 (BD-1/hBD-1) full length peptide (36 aa), biologically active |
HBD17-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2324.4 |
Recombinant (E. coli), purified, Human beta-Defensin 1 (BD-1/hBD-1) full length peptide (36 aa), biologically active |
HBD17-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 6637.2 |
Recombinant (E. coli), purified, Human beta-Defensin 2 (BD-2/hBD-2) full length peptide (41 aa), biologically active |
HBD25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (E. coli), purified, Human beta-Defensin 2 (BD-2/hBD-2) full length peptide (41 aa), biologically active |
HBD25-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2617.2 |
Recombinant (E. coli), purified, Human beta-Defensin 2 (BD-2/hBD-2) full length peptide (41 aa), biologically active |
HBD25-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 7221.6 |
Recombinant (E.Coli) purified rat Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA25-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Recombinant (E.Coli) purified mouse Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA35-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha Variant (TNF-alpha variant, 151-aa), biologically active |
TNFA16-R-10 |
Alpha Diagnostics |
10 ug |
EUR 270 |
Recombinant (E.Coli) purified porcine Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA36-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Human Calcineurin A-subunit protein biologically active |
CALNA15-R |
Alpha Diagnostics |
1000 U |
EUR 416.4 |
Human Recombinant VEGF121 Protein (Sf9), biologically active |
VEGF24-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF121 Protein (Sf9), biologically active |
VEGF24-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF165 Protein (Sf9), biologically active |
VEGF27-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF165 Protein (HEK), biologically active |
VEGF27-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF165 Protein (Sf9), biologically active |
VEGF27-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 11022 |
Human Recombinant VEGF121 Protein (E.Coli), biologically active |
VEGF25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF121 Protein (E.Coli), biologically active |
VEGF25-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2690.4 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 11022 |
Human Recombinant EG-VEGF Protein (84aa, E. Coli), biologically active |
VEGF36-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2389.2 |
Human Recombinant EG-VEGF Protein (84aa, E. coli), biologically active |
VEGF36-R-20 |
Alpha Diagnostics |
20 ug |
EUR 927.6 |
Human Recombinant EG-VEGF Protein (84aa, E. coli), biologically active |
VEGF36-R-5 |
Alpha Diagnostics |
5 ug |
EUR 388.8 |
Human Pancreatic Lipase (partially pure) biologically active |
PLIP15-N |
Alpha Diagnostics |
10 U |
EUR 343.2 |
Lipase, Human Pancreas (biologically active) antigen grade (.95% pure) |
PLIP15-N-10 |
Alpha Diagnostics |
10 ug |
EUR 343.2 |
Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active |
PLGF15-R-25 |
Alpha Diagnostics |
25 ug |
EUR 634.8 |
Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active |
PLGF15-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Rat Recombinant VEGF152 (VEGF-C) Protein (Sf9), biologically active |
VEGF31-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Rat Recombinant VEGF129 (VEGF-C) Protein (Sf9), biologically active |
VEGF32-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Rat Recombinant VEGF129 (VEGF-C) Protein (Sf9), biologically active |
VEGF32-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Rat Recombinant VEGF164 (VEGF-A) Protein (E.Coli), biologically active |
VEGF33-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Rat Recombinant VEGF164 (VEGF-A) Protein (E.Coli), biologically active |
VEGF33-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2973.6 |
Mouse Recombinant VEGF164 (VEGF-A) Protein (Sf9), biologically active |
VEGF34-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Mouse Recombinant VEGF164 (VEGF-A) Protein (Sf9), biologically active |
VEGF34-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2973.6 |
Mouse Recombinant VEGF165 (VEGF-A) Protein (E.Coli), biologically active |
VEGF35-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Mouse Recombinant VEGF165 (VEGF-A) Protein (E.Coli), biologically active |
VEGF35-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2690.4 |
Recombinant (HEK) Human VEGFR1/FLT1 Protein (1-328aa-IgG1-Fc, >95%, ~67 kda, low endotoxin), biologically active |
VEGFR15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (HEK) Human VEGFR2/Kdr/FLK1 Protein (1-764aa-IgG-Fc, >95%, ~160 kda, low endotoxin), biologically active |
VEGFR25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (plant) Human Apotransferrin, Tissue Culture Grade (animal free, biologically active, >95% pure |
TF27-N-100 |
Alpha Diagnostics |
100 mg |
EUR 270 |
Recombinant (plant) Human Apotransferrin, Tissue Culture Grade (animal free, biologically active, >95% pure |
TF27-N-1000 |
Alpha Diagnostics |
100 mg |
EUR 781.2 |
Human Recombinant Transforming Growth Factor-alpha (TGF-alpha), biologically active |
TGFA15-R-100 |
Alpha Diagnostics |
100 ug |
EUR 634.8 |
Human Recombinant Transforming Growth Factor-alpha (TGF-alpha), biologically active |
TGFA15-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 4225.2 |
Human Recombinant Transforming Growth Factor-alpha (TGF-alpha), biologically active |
TGFA15-R-20 |
Alpha Diagnostics |
20 ug |
EUR 270 |
Purified Human Plasminogen protein W. Blot Positive control |
PLMN11-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Recombinnat purified Human Plasminogen Activator Inhibitor 1 (PAI-1) protein (his-tag) control for ELISA |
PAI21-R-25 |
Alpha Diagnostics |
25 ug |
EUR 343.2 |
Human Plasminogen (Plg) Protein (Active) |
20-abx655799 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Plasminogen (Plg) Protein (Active) |
20-abx655800 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Plasminogen (PLG) Protein (Active) |
abx655799-100g |
Abbexa |
100 µg |
EUR 325 |
Human Plasminogen (PLG) Protein (Active) |
abx655800-100g |
Abbexa |
100 µg |
EUR 325 |
*Human Plasminogen Glu Affinity Purified |
IHUPLGGLUAP10MG |
Innovative research |
each |
EUR 1807 |
|
Description: *Human Plasminogen Glu Affinity Purified |
*Human Plasminogen Glu Affinity Purified |
IHUPLGGLUAP1MG |
Innovative research |
each |
EUR 294 |
|
Description: *Human Plasminogen Glu Affinity Purified |
Recombinnat purified Human Plasminogen Activator Inhibitor 1 (PAI-1) protein (his-tag) control for Western blot |
PAI21-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Recombinant Human Plasminogen protein(PLG) (Active) |
AP73562 |
SAB |
1mg |
EUR 1989 |
|
Recombinant Human Plasminogen protein (PLG) (Active) |
MBS969344-001mg |
MyBiosource |
0.01mg |
EUR 210 |
Recombinant Human Plasminogen protein (PLG) (Active) |
MBS969344-01mg |
MyBiosource |
0.1mg |
EUR 535 |
Recombinant Human Plasminogen protein (PLG) (Active) |
MBS969344-05mg |
MyBiosource |
0.5mg |
EUR 1090 |
Recombinant Human Plasminogen protein (PLG) (Active) |
MBS969344-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4635 |
*Human Plasminogen Glu Purified FITC Labeled |
IHUPLGFITC10MG |
Innovative research |
each |
EUR 1868 |
|
Description: *Human Plasminogen Glu Purified FITC Labeled |
*Human Plasminogen Glu Purified FITC Labeled |
IHUPLGFITC1MG |
Innovative research |
each |
EUR 234 |
|
Description: *Human Plasminogen Glu Purified FITC Labeled |
*Rat Plasminogen Purified |
IRTPLG10MG |
Innovative research |
each |
EUR 2842 |
|
Description: *Rat Plasminogen Purified |
*Rat Plasminogen Purified |
IRTPLG1MG |
Innovative research |
each |
EUR 422 |
|
Description: *Rat Plasminogen Purified |
*Horse Plasminogen Purified |
IHSPLG10MG |
Innovative research |
each |
EUR 1421 |
|
Description: *Horse Plasminogen Purified |
*Horse Plasminogen Purified |
IHSPLG1MG |
Innovative research |
each |
EUR 178 |
|
Description: *Horse Plasminogen Purified |
*Mouse Plasminogen Purified |
IMSPLG1MG |
Innovative research |
each |
EUR 178 |
|
Description: *Mouse Plasminogen Purified |
Recombinant Human Plasminogen protein (PLG), partial (Active) |
CSB-AP002261HU |
Cusabio |
8534 mg |
Ask for price |
*Sheep Anti Human Plasminogen Polyclonal Affinity Purified |
ISHAHUPLGAP100UG |
Innovative research |
each |
EUR 230 |
|
Description: *Sheep Anti Human Plasminogen Polyclonal Affinity Purified |
*Sheep Anti Human Plasminogen Polyclonal Affinity Purified |
ISHAHUPLGAP1MG |
Innovative research |
each |
EUR 1834 |
|
Description: *Sheep Anti Human Plasminogen Polyclonal Affinity Purified |
Human Factor I (Fibrinogen) Plasminogen Depleted Purified |
IHUFBGPLGD25MG |
Innovative research |
each |
EUR 140 |
|
Description: Human Factor I (Fibrinogen) Plasminogen Depleted Purified |
Human Factor I (Fibrinogen) Plasminogen Depleted Purified |
MBS8411598-25mg |
MyBiosource |
25mg |
EUR 285 |
Human Factor I (Fibrinogen) Plasminogen Depleted Purified |
MBS8411598-5x25mg |
MyBiosource |
5x25mg |
EUR 1045 |
*Horse Plasminogen Affinity Purified |
IHSPLGAP10MG |
Innovative research |
each |
EUR 1493 |
|
Description: *Horse Plasminogen Affinity Purified |
*Horse Plasminogen Affinity Purified |
IHSPLGAP1MG |
Innovative research |
each |
EUR 187 |
|
Description: *Horse Plasminogen Affinity Purified |
Horse Plasminogen Affinity Purified |
MBS136599-10mg |
MyBiosource |
10mg |
EUR 1930 |
Horse Plasminogen Affinity Purified |
MBS136599-1mg |
MyBiosource |
1mg |
EUR 335 |
Horse Plasminogen Affinity Purified |
MBS136599-5x10mg |
MyBiosource |
5x10mg |
EUR 8450 |
*Bovine Plasminogen Affinity Purified |
IBOPLGAP10MG |
Innovative research |
each |
EUR 1599 |
|
Description: *Bovine Plasminogen Affinity Purified |
*Bovine Plasminogen Affinity Purified |
IBOPLGAP1MG |
Innovative research |
each |
EUR 261 |
|
Description: *Bovine Plasminogen Affinity Purified |
*Canine Plasminogen Affinity Purified |
ICNPLGAP10MG |
Innovative research |
each |
EUR 3248 |
|
Description: *Canine Plasminogen Affinity Purified |
*Canine Plasminogen Affinity Purified |
ICNPLGAP1MG |
Innovative research |
each |
EUR 443 |
|
Description: *Canine Plasminogen Affinity Purified |
*Rabbit Plasminogen Affinity Purified |
IRBPLGAP10MG |
Innovative research |
each |
EUR 2985 |
|
Description: *Rabbit Plasminogen Affinity Purified |
*Rabbit Plasminogen Affinity Purified |
IRBPLGAP1MG |
Innovative research |
each |
EUR 453 |
|
Description: *Rabbit Plasminogen Affinity Purified |
*Chicken Plasminogen Affinity Purified |
ICHPLGAP10MG |
Innovative research |
each |
EUR 2132 |
|
Description: *Chicken Plasminogen Affinity Purified |
*Chicken Plasminogen Affinity Purified |
ICHPLGAP1MG |
Innovative research |
each |
EUR 315 |
|
Description: *Chicken Plasminogen Affinity Purified |
*Porcine Plasminogen Affinity Purified |
IPCPLGAP10MG |
Innovative research |
each |
EUR 2410 |
|
Description: *Porcine Plasminogen Affinity Purified |
*Porcine Plasminogen Affinity Purified |
IPCPLGAP1MG |
Innovative research |
each |
EUR 272 |
|
Description: *Porcine Plasminogen Affinity Purified |
Human Plasminogen Activator Inhibitor 2 (PAI2) Protein (Active) |
20-abx655801 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Plasminogen Activator Inhibitor 2 (PAI2) Protein (Active) |
abx655801-100g |
Abbexa |
100 µg |
EUR 2825 |
Rat Plasminogen (Plg) Protein (Active) |
20-abx651431 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Plasminogen (PLG) Protein (Active) |
abx651431-5mg |
Abbexa |
5 mg |
EUR 850 |
Affinity Purified Goat anti-Human Plasminogen |
MBS560410-1mg |
MyBiosource |
1mg |
EUR 205 |
Affinity Purified Goat anti-Human Plasminogen |
MBS560410-5x1mg |
MyBiosource |
5x1mg |
EUR 865 |
Sheep anti-human plasminogen, affinity purified |
MBS135233-01mg |
MyBiosource |
0.1mg |
EUR 380 |
Sheep anti-human plasminogen, affinity purified |
MBS135233-1mg |
MyBiosource |
1mg |
EUR 2350 |
Sheep anti-human plasminogen, affinity purified |
MBS135233-5x1mg |
MyBiosource |
5x1mg |
EUR 10335 |
Sheep anti-human plasminogen, affinity purified |
MBS480369-01mg |
MyBiosource |
0.1mg |
EUR 455 |
Sheep anti-human plasminogen, affinity purified |
MBS480369-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1830 |
Anti Murine plasminogen Affinity purified |
MBS480247-01mg |
MyBiosource |
0.1mg |
EUR 710 |
Anti Murine plasminogen Affinity purified |
MBS480247-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2990 |
*Monkey Cynomolgus Plasminogen Affinity Purified |
IMNCYPLGAP10MG |
Innovative research |
each |
EUR 3638 |
|
Description: *Monkey Cynomolgus Plasminogen Affinity Purified |
*Monkey Cynomolgus Plasminogen Affinity Purified |
IMNCYPLGAP1MG |
Innovative research |
each |
EUR 455 |
|
Description: *Monkey Cynomolgus Plasminogen Affinity Purified |
Rabbit anti mouse plasminogen, affinity purified |
MBS135134-01mg |
MyBiosource |
0.1mg |
EUR 630 |
Rabbit anti mouse plasminogen, affinity purified |
MBS135134-1mg |
MyBiosource |
1mg |
EUR 4760 |
Recombinant Human Plasminogen activator inhibitor 2 protein(SERPINB2) (Active) |
AP73553 |
SAB |
1mg |
EUR 6829 |
|
Recombinant Human Plasminogen activator inhibitor 2 protein (SERPINB2) (Active) |
CSB-AP000151HU |
Cusabio |
8506 mg |
Ask for price |
Recombinant Human Plasminogen activator inhibitor 2 protein (SERPINB2) (Active) |
MBS969133-001mg |
MyBiosource |
0.01mg |
EUR 355 |
Recombinant Human Plasminogen activator inhibitor 2 protein (SERPINB2) (Active) |
MBS969133-01mg |
MyBiosource |
0.1mg |
EUR 1590 |
Recombinant Human Plasminogen activator inhibitor 2 protein (SERPINB2) (Active) |
MBS969133-05mg |
MyBiosource |
0.5mg |
EUR 3395 |
Recombinant Human Plasminogen activator inhibitor 2 protein (SERPINB2) (Active) |
MBS969133-5x05mg |
MyBiosource |
5x0.5mg |
EUR 15240 |
Active Plasminogen (Plg) |
APB236Hu01 |
Cloud-Clone |
10ug |
EUR 130 |
Active Plasminogen (Plg) |
4-APB236Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Active Plasminogen (Plg) expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Active Plasminogen (Plg) |
4-APB236Hu51 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Plasminogen expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Active Plasminogen (Plg) |
APB236Ra01 |
Cloud-Clone |
10ug |
EUR 280 |
Active Plasminogen (Plg) |
4-APB236Ra01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat Plasminogen expressed in: E.coli |
Active Plasminogen (Plg) |
MBS2105131-001mg |
MyBiosource |
0.01mg |
EUR 150 |
Active Plasminogen (Plg) |
MBS2105131-005mg |
MyBiosource |
0.05mg |
EUR 245 |
Active Plasminogen (Plg) |
MBS2105131-01mg |
MyBiosource |
0.1mg |
EUR 350 |
Active Plasminogen (Plg) |
MBS2105131-02mg |
MyBiosource |
0.2mg |
EUR 430 |
Active Plasminogen (Plg) |
MBS2105131-05mg |
MyBiosource |
0.5mg |
EUR 800 |
Active Plasminogen (Plg) |
MBS2105132-001mg |
MyBiosource |
0.01mg |
EUR 150 |
The truth is, scientific developments at such an accelerated tempo have already negatively affected our cultural, moral, and authorized values and our capability to harness the alternatives and face the risks posed by such developments. As a matter of reality, science appears to persistently outpace public morals, ethics and policymaking, which requires a excessive diploma of warning and customary solutions.